Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population

Diabetes Care

Volumn 29, Issue 8, 2006, Pages 1931-1932

  Marso, Steven P ^a,b   Safley, David M ^a   House, John A ^a   Tessendorf, Todd ^a   Reid, Kimberly J ^a   Spertus, John A ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; TROPONIN I;

ACUTE CORONARY SYNDROME; ARTICLE; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; HEART INFARCTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; CORONARY DISEASE; DIABETES MELLITUS; HUMANS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TROPONIN I;

EID: 33746639951     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0660     Document Type: Article

References (13)

1. Braunwald E, Antman E, Beasley J, Califf R, Cheitlin M, Hochman J, Jones R, Kereiakes D, Kupersmith J, Levin T, Pepine C, Schaeffer J, Smith EI, Steward D, Theroux P: ACC/AHA 2002 Guideline Update for the Management of Patients With Unstable Angina and Non-ST-segment Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Bethesda, MD, American College of Cardiology, 2002
2. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284:835-842, 2000
3. Cannon CP: Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial. J Am Coll Cardiol 41:43S-48S, 2003
4. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial: FRISC II Investigators: fast revascularisation during instability in coronary artery disease. Lancet 356:9-16, 2000
5. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, Akkerhuis KM, Harrington RA, Deckers JW, Armstrong PW, Lincoff AM, Califf RM, Topol EJ, Simoons ML: Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients: the PURSUIT In vestigators. Circulation 101:2557-2567, 2000
6. Theroux P, Alexander J Jr, Pharand C, Barr E, Snapinn S, Ghannam AF, Sax FL: Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study. Circulation 102:2466-2472, 2000
7. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E: An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 23:223-229, 2002
8. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36:959-969, 2000
9. Braunwald E: Unstable angina: a classification. Circulation 80:410-414, 1989
10. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144, 2002
11. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM: Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 164:1457-1463, 2004
12. James SK, Lindahl B, Timmer JR, Ottervanger JP, Siegbahn A, Stridsberg M, Armstrong P, Califf R, Wallentin L, Simoons ML: Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). Am J Cardiol 97:167-172, 2006
13. Aguilar D, Solomon SD, Kober L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA: Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 110:1572-1578, 2004